Study guide
3.1 OSHA Bloodborne Pathogens and Needlestick Safety
AMT Certified Medical Laboratory Assistant CMLA
Track your progress as you read
Finished sections get a check mark.
1 Introduction
1.1 Current Exam Facts 1.2 Blueprint Weights and Study Strategy
2 Chapter 2: Safety Terminology and Infection Control
2.1 Safety, Infection, and OSHA Terminology 2.2 Chain of Infection and Precautions 2.3 Isolation, Aseptic Technique, and Disease Prevention
3 Chapter 3: OSHA, HazCom, and Public-Health Reporting
3.1 OSHA Bloodborne Pathogens and Needlestick Safety 3.2 Hazard Communication, SDS, and GHS 3.3 Mandated Safety Rules and Public-Health Reporting
4 Chapter 4: Quality Assessment and Quality Control
4.1 Quality Control and Assessment Terminology 4.2 QC vs QA, Internal vs External QC, and Proficiency Testing 4.3 Daily QC, Temperature Logs, and Corrective Action 4.4 Instrument Maintenance and Calibration in CMLA Scope
5 Chapter 5: Waived-Test Integrity and Confirmatory Testing
5.1 Off-Label Waived Testing and High-Complexity Default 5.2 Following Manufacturer Instructions for Waived Tests 5.3 Confirmatory and Supplemental Testing
6 Chapter 6: Phlebotomy Foundations
6.1 Phlebotomy Terminology and Equipment 6.2 Serum, Plasma, Whole Blood, and Anticoagulation 6.3 Patient Identification and Container Identification
7 Chapter 7: Venipuncture, Order of Draw, and Specimen Integrity
7.1 Patient Preparation and Physiologic Effects 7.2 Vein Selection and Venipuncture Technique 7.3 Order of Draw and Tube Additives 7.4 Short Draws, Hemolysis, and Plasma-on-Cells Limits
8 Chapter 8: Capillary Collection, Processing, and Legal Specimens
8.1 Capillary Puncture Including Infants 8.2 Post-Care, Labeling, Transport, Processing, and Send-Outs 8.3 Specimens Used as Legal Evidence
9 Chapter 9: Non-Blood Collection and Preanalytical Errors
9.1 Urine Collection Types and Patient Instruction 9.2 Urine Suitability, Storage, Preservatives, and Rejection 9.3 Other Specimens and Time/Temperature Requirements 9.4 Shipping, Slide Prep, Preanalytical Errors, and Complications
10 Chapter 10: Clinical Chemistry
10.1 Clinical Chemistry Terminology and Test Families 10.2 Chemistry Instrumentation, Cleaning, and Maintenance 10.3 Point-of-Care and Waived Chemistry Testing 10.4 Toxicology Within CMLA Scope
11 Chapter 11: Hematology and Coagulation
11.1 Hematology Terminology, Blood Functions, and Cell Types 11.2 Hematology Instrumentation, QC, and Calibration 11.3 Coagulation: PT, PTT, INR, Heparin, and Warfarin 11.4 Point-of-Care and Waived Hematology Tests
12 Chapter 12: Immunology, Serology, and Immunohematology
12.1 Antigen-Antibody Principles 12.2 Blood Types, Rh, and Immunohematology Basics 12.3 Waived Immunology, Serology, and Immunohematology Procedures
13 Chapter 13: Microbiology
13.1 Microbiology Terminology and Specimen Appropriateness 13.2 Aseptic Processing, Storage, and Transport of Micro Specimens 13.3 Media, Cultures, and Procedure Matching 13.4 Stains, KOH, Wet Preps, Reagents, and Controls
14 Chapter 14: Urinalysis and Microscopy
14.1 Urinalysis Terminology 14.2 Waived Urinalysis Procedures and Specimen Handling 14.3 Microscopy Parts, Magnification, Wet Prep, and Cleaning
15 Chapter 15: Basic Anatomy and Physiology
15.1 Anatomy Relevant to Laboratory Testing 15.2 Physiology Relevant to Laboratory Testing
16 Chapter 16: Legal, Ethical, and HIPAA Foundations
16.1 Consent, ABN, Test Ordering, and PPM Restrictions 16.2 Patient's Bill of Rights, Refusal, and Medicolegal Risk 16.3 Professional Appearance, Conduct, and Social Media 16.4 HIPAA Confidentiality and Record Release
17 Chapter 17: Clerical Skills, Communication, and Critical Values
17.1 Reports, Abnormal Results, and Critical-Value Notification 17.2 HIT Data, Inventory, Expirations, and Billing/Coding 17.3 Patient Instruction, Communication, Telephone, and Time Management
3.1 OSHA Bloodborne Pathogens and Needlestick Safety
Key Takeaways Explain This Topic AI
29 CFR 1910.1030 is OSHA's Bloodborne Pathogens Standard; it covers occupational exposure to blood and other potentially infectious materials (OPIM) and requires a written, annually reviewed exposure control plan.
Engineering controls isolate the hazard: safety-engineered needles, needleless systems, and puncture-resistant, upright, labeled sharps containers that are never overfilled.
Contaminated needles must not be bent or recapped with two hands; if recapping is unavoidable, OSHA allows only a mechanical device or a one-handed scoop.
Hepatitis B vaccination must be offered at no cost after BBP training and within 10 working days of initial assignment; a signed OSHA declination keeps the vaccine available later at no cost.
The Needlestick Safety and Prevention Act (2000) requires safer medical devices, input from non-managerial employees who do the work, and a sharps injury log with device type/brand, work area, and how the injury occurred.
Last updated: August 2026
The Occupational Safety and Health Administration (OSHA) Bloodborne Pathogens (BBP) Standard , 29 CFR 1910.1030 , is the federal rule that protects workers from human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and other bloodborne pathogens. For the Certified Medical Laboratory Assistant (CMLA), this is daily practice, not background reading. Venipuncture, capillary collection, waived whole-blood testing, and specimen processing all create occupational exposure —reasonably anticipated contact with blood or other potentially infectious materials (OPIM) through the eye, mouth, other mucous membrane, non-intact skin, or a parenteral route (needlestick, lancet, broken tube, or other sharp).
Quick Answer: Follow the facility exposure control plan . Use engineering controls first (safety needles, needleless systems, puncture-resistant sharps containers), then work-practice controls (no two-handed recapping, activate the safety device immediately, never overfill a sharps container), then personal protective equipment (PPE) . Complete HBV vaccination or a signed OSHA declination, and treat every needlestick or blood splash as an exposure that starts immediate first aid and confidential post-exposure evaluation.
Blood, OPIM, and What the Standard Covers
Blood means human blood, blood components, and products made from human blood. OPIM includes semen, vaginal secretions, cerebrospinal fluid, synovial fluid, pleural fluid, peritoneal fluid, pericardial fluid, amniotic fluid, saliva in dental procedures, any body fluid visibly contaminated with blood, all body fluids when it is difficult or impossible to differentiate them, unfixed human tissues or organs, and HIV- or HBV-containing culture materials.
Sweat, tears, nasal secretions, and saliva are not automatically OPIM unless they are visibly bloody or fluids cannot be classified. That exception is not a license to skip gloves. Standard Precautions still treat every blood specimen—and every unlabeled wet specimen you cannot categorize—as infectious.
- Material How 1910.1030 treats it
- Whole blood, serum, plasma, packed cells Blood — always covered
- CSF, synovial, pleural, peritoneal, pericardial, amniotic fluid OPIM — always covered
Urine, feces, sputum, vomitus with no visible blood Not automatically OPIM; still handle under Standard Precautions
- Used needles, lancets, capillary tubes, blood-smeared slides Contaminated sharps — regulated waste
- The Exposure Control Plan
Every employer with occupational exposure must maintain a written exposure control plan . The plan lists job classifications with exposure (phlebotomist, laboratory assistant, point-of-care testing staff), names tasks that create exposure, and describes methods of compliance. It must be accessible during the work shift . OSHA requires at least annual review and an update whenever new tasks, procedures, or devices change the exposure picture. After 2000, the plan must also document evaluation of safer devices and input from the people who actually draw and process specimens.
The CMLA does not author the plan. You are expected to know that it exists, where it is kept, and that a personal shortcut does not override it.
Engineering Controls, Work Practices, and PPE
OSHA ranks protections. Engineering controls isolate or remove the hazard from the workplace. Work-practice controls change how you perform the task. PPE is the last line of defense—it never replaces a safety needle or a sharps container.
Control type What it does CMLA examples
Engineering Isolates or removes the hazard Puncture-resistant sharps containers; self-sheathing or retracting safety needles; hinged-cap devices; needleless transfer systems; splash shields
Work practice Changes behavior to cut exposure No two-handed recapping; activate the safety feature immediately after use; hand hygiene after glove removal; no eating, drinking, or applying cosmetics in the lab; no mouth pipetting
PPE Barrier on the worker Gloves for every collection and specimen handling; fluid-resistant gown when splash is reasonably anticipated; mask and eye protection for splash risk
Sharps containers and safety devices
A compliant sharps container is closable, puncture-resistant, and leakproof on sides and bottom , labeled with the biohazard symbol or color-coded red, kept upright , placed as close as feasible to the point of use, and replaced before it is overfilled . The fill line is a hard stop. Pushing one more device into a full container is a classic delayed needlestick—an engineering control defeated by a work-practice failure.
Activate the safety feature immediately after the needle leaves the patient, before you walk with an exposed sharp. Needleless transfer devices replace the old habit of using a needle to move blood from a syringe into a tube. If a device has a safety mechanism and you skip it, you have not used the engineering control OSHA requires.
Recapping bans
Contaminated needles must not be bent, recapped, or removed unless the employer can demonstrate that no alternative is feasible or that a specific medical or dental procedure requires it. When recapping is truly unavoidable, it must be done with a mechanical device or a one-handed scoop —never two hands. For routine venipuncture and capillary work, the sequence is: activate the safety device, then straight into the sharps container. Two-handed recapping is always wrong on this exam.
Leaving the container across the room is not an excuse to recap. Move the container to the chairside or bedside. Carrying an unprotected used needle down a hallway is the problem the standard was written to stop.
HBV Vaccination
Employers must offer the hepatitis B vaccine and vaccination series at no cost to employees with occupational exposure, after required BBP training and within 10 working days of initial assignment . An employee may decline, but only by signing the OSHA declination form (Appendix A to 1910.1030). Declining does not close the door: the vaccine must remain available later at no cost if the employee changes their mind. Post-vaccination anti-HBs testing, when the occupational-health protocol calls for it, documents whether the series produced immunity. HBV vaccination does not protect against HIV or HCV, so controls and PPE still apply after you complete the series.
Post-Exposure Evaluation and Blood Spills
A needlestick, lancet stick, or splash of blood or OPIM to eyes, mouth, or non-intact skin is an exposure incident . First aid comes first:
Needlestick or cut: wash with soap and water. Do not squeeze the wound as a ritual, and do not inject bleach or disinfectant into tissue.
Splash to eyes or mucous membranes: flush at the eyewash (or with clean water or saline) immediately, then report. In a BBP event the eyewash is first aid for a blood or OPIM splash. Chemical-spill neutralization, SDS Section 6, and acid/base response belong to Hazard Communication, not this standard.
Report the incident at once. OSHA requires a confidential medical evaluation and follow-up : documentation of the route and circumstances, identification and testing of the source individual if legally feasible, baseline testing of the exposed employee (with consent), counseling, and post-exposure prophylaxis (PEP) as recommended by the U.S. Public Health Service. The employer pays. Source-patient results are disclosed to the exposed employee so PEP decisions can be made; the employee's own results remain confidential.
For a blood spill , stop traffic, don PPE, absorb the material, and decontaminate with an EPA-registered disinfectant effective against HBV and HIV, or with freshly prepared approximately 1:10 sodium hypochlorite (bleach) when that is the facility-approved product. Broken glass in blood is picked up with forceps or a scoop—never fingers. Do not treat a mixed chemical-and-blood spill as a simple red-bag event; once a hazardous chemical is involved, the SDS and chemical-hygiene rules join the BBP rules.
Regulated Waste
Regulated waste includes liquid or semi-liquid blood or OPIM; items that would release blood or OPIM if compressed; items caked with dried blood or OPIM that could flake during handling; contaminated sharps; and pathological or microbiological wastes containing blood or OPIM. Place it in closable, leak-resistant, labeled or red containers. Sharps never go in a thin trash bag. Close the container before it leaves the area.
Needlestick Safety and Prevention Act (2000)
The Needlestick Safety and Prevention Act (Public Law 106-430, 2000)—the statute the AMT outline refers to as the Needle Safety Precaution Act—amended 1910.1030. Employers must evaluate and implement safer medical devices (engineered sharps-injury protection and needleless systems), solicit input from non-managerial employees who perform direct patient care when selecting those devices, and maintain a sharps injury log (for employers already required to keep OSHA injury records). The log records the type and brand of device , the department or work area , and an explanation of how the incident occurred , written so confidentiality is protected. Annual review of the log is how a laboratory spots a bad device or a bad technique.
Assistant Scenarios the Exam Likes
A capillary glucose is done at the chair. The safety lancet is not activated, and the device is dropped into a sharps container that is already above the fill line. Two failures occurred: the engineering control on the device was not used, and the container was no longer an engineering control because it was overfilled.
A syringe draw is transferred with a needle into a vacuum tube instead of a needleless transfer device that is sitting in the same drawer. The available safer device was not used.
An assistant recaps "just this once" because the patient is watching. Witnesses do not create an OSHA exception. Activate the safety feature in view of the patient; that is part of the standard of care, not a hidden step.